Prolonged vs Short Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With or Without Peripheral Arterial Disease

Anna Franzone(University Hospital of Bern), Marco Valgimigli(University of Bern)
JAMA Cardiology
August 30, 2016
10.1001/jamacardio.2016.2811
Cited by 91

Related Papers

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|753
Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI
|Journal of the American College of Cardiology|2016|438
European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism
|European Heart Journal|2018|435
Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trials
|European Heart Journal|2015|371